A start-up company creating synthetic blood vessels for transplants, based on research in materials science and cell biology, is raising $2.2 million in seed funds. . . . → Read More: Synthetic Blood Vessel Maker Gains $2.2M in Seed Funds
|
|||||
|
       
  |
A new enterprise discovering treatments for neurodegenerative diseases is merging with another start-up and raising $73 million its first venture round. . . . → Read More: Neuro Disease Start-Up Raises $73M in Early Funds  One comment - (Comments are closed)  Finance, New products  biomedical, biotechnology, entrepreneurs, equity, Europe, genomics, investment, life sciences, merger, pharmaceuticals, university, venture capital 
A therapy designed to regenerate healthy gut microbes for treating dangerous intestinal infections is licensed for commercialization to Nestlé Health Science. . . . → Read More: Microbiome Drug Candidate Licensed in $525M Deal Comments are closed Intellectual property, New products biomedical, biotechnology, clinical trials, Europe, licensing, life sciences, pharmaceuticals 
Two biotechnology companies are designing therapies to deliver edited genes to treat Friedreich’s ataxia and amyotrophic lateral sclerosis, or ALS. . . . → Read More: Biotechs Partner on Crispr Therapies for Neuro Disorders One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, biotechnology, Europe, genomics, life sciences, manufacturing, pharmaceuticals 
Chemists at industry and academic labs created safer lipids for delivering messenger RNA vaccines, such as those protecting against Covid-19. . . . → Read More: Plant-Based Lipids Developed for mRNA Vaccines One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, biotechnology, chemistry, Covid-19, engineering, Europe, life sciences, manufacturing, nanotechnology, pharmaceuticals, physical sciences, university 
Two biotechnology companies are collaborating on using the gene editing technique Crispr to create engineered immune-system cells to treat cancer. . . . → Read More: Biotechs Partner on Gene-Edited Cancer Cell Therapies 2 comments - (Comments are closed) Intellectual property, Joint ventures/collaborations biomedical, biotechnology, cancer, Europe, genomics, licensing, life sciences, pharmaceuticals 
Moderna Inc. is providing up to 500 million doses of its Covid-19 vaccine to the Covax Facility, an international project distributing vaccines to low-income countries. . . . → Read More: Moderna Supplying 500M Vaccine Doses to Covax Comments are closed Joint ventures/collaborations biomedical, biotechnology, Covid-19, Europe, health care, life sciences, pharmaceuticals 
A study with lab mice shows an experimental vaccine with engineered bacteria produces antibodies and protects against microbes causing Lyme disease. . . . → Read More: Vaccine Stops Lyme Bacteria in Preclinical Test Comments are closed New products biomedical, biotechnology, Europe, genomics, life sciences, pharmaceuticals, preclinical, university 
A clinical trial is underway testing for allergic reactions to Covid-19 vaccines using messenger RNA for invoking an immune response. . . . → Read More: NIH Trial Testing mRNA Vaccine Allergic Effects One comment - (Comments are closed) New products, Regulations biomedical, biotechnology, clinical trials, Covid-19, Europe, genomics, life sciences, NIH, pharmaceuticals 
Results of a clinical trial show an anti-microbial treatment for Covid-19 infections given as a nasal spray is safe and well-tolerated in healthy volunteers. . . . → Read More: Trial Shows Inhaled Covid-19 Therapy Safe One comment - (Comments are closed) New products biomedical, biotechnology, clinical trials, Covid-19, Europe, life sciences, pharmaceuticals, university |
||||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||